Anera Life Inc. is proud to announce the appointment of Dr. Keith Moeller, ND, to its Scientific Advisory Board expanding the company’s scientific leadership with one of the world’s foremost pioneers in nano-silver biotechnology, antimicrobial innovation, and applied clinical research.
A Global Leader in Nano-Metallic Silver Technology
Dr. Moeller is the Founder and CEO of SilverCeuticals, Inc., a Utah-based biotechnology company specializing in advanced Nano-Silver Oxide technologies. Founded in 2022, SilverCeuticals has rapidly established itself as the leading manufacturer of Nano-Metallic Silver Oxide (NMSTTO) and has earned multiple Best of State awards in Medical Innovation and Applied Science. Their work represents one of the most advanced applications of nano-silver in medicine, infectious disease control, and emerging cellular therapeutics.
Professional Background & Scientific Credentials
Dr. Moeller is a Certified Natural Health Professional and holds a Doctorate in Naturopathic Medicine. Over the past two decades, he has played a central role in advancing nano-metallic silver research into real-world medical, dental, military, and consumer applications.
His scientific work includes:
Testifying before the United States Congress on the clinical value of Nano-Metallic Silver Tetrahedral TetraOxide (NMSTTO) as a potential solution against malaria and other global pathogens.
Receiving honorary membership from the U.S. Special Operations Medical Association for his contributions in treating drug-resistant infections in military personnel.
Co-authoring multiple peer-reviewed scientific publications on viruses, bacteria, and biofilms.
Leading research and patent filings in oncology, infectious disease, regenerative medicine, veterinary applications, and now—longevity therapeutics.
A Longstanding Scientific Partnership
Dr. Moeller has collaborated for over 20 years with Dr. Andrew J.M. Willoughby, DMD, LVIF, FAGD, FICOI, FICCMO, FAACFP, MICCMO, President and Chief Science Officer of Anera Life Inc. Together, they have helped pioneer new applications for NMSTTO in Botulinum Neurotoxin treatments, and have been issued 19 patents worldwide on this particular topic. They have also pioneered numerous new dental procedures, products and protocols in the dental and related health care market places. Their work has been featured on PBS’s Medical Innovations and has laid the scientific foundation for several cross-disciplinary patents.
Now, that same expertise is being directed toward longevity medicine and nutraceutical innovation, bringing a patented medical technology into the supplement and healthspan industry for the first time.
Advancing Anera’s Scientific Mission
Dr. Moeller’s appointment marks an important moment in Anera’s evolution. His contributions solidify Anera Life Inc. as a company guided by rigorous scientific leadership and directed toward meaningful breakthroughs in cellular resilience, immune defense, and long-term regenerative health.
By welcoming Dr. Moeller to the Scientific Advisory Board, Anera continues its mission to bridge clinical science, pharmaceutical-grade formulation, and next-generation health optimization all in service of helping heal humanity.
